CIC-REARRANGED SARCOMA
Clinical trials for CIC-REARRANGED SARCOMA explained in plain language.
Never miss a new study
Get alerted when new CIC-REARRANGED SARCOMA trials appear
Sign up with your email to follow new studies for CIC-REARRANGED SARCOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New drug trial targets rare sarcomas
Disease control OngoingThis early-stage study tests a new drug called BTX-A51 in 24 people with advanced liposarcoma that has spread or come back. The main goal is to check if the drug is safe and tolerable at two different doses. Researchers will also watch for any tumor shrinkage or slowing of the di…
Matched conditions: CIC-REARRANGED SARCOMA
Phase: PHASE1 • Sponsor: Michael Wagner, MD • Aim: Disease control
Last updated May 17, 2026 03:00 UTC
-
New drug shows promise in halting bone sarcoma growth
Disease control OngoingThis study tests whether the drug regorafenib can stop or slow the growth of bone sarcomas that have spread to other parts of the body. About 163 patients with advanced osteosarcoma, Ewing sarcoma, chondrosarcoma, or chordoma will receive either regorafenib or a placebo. The main…
Matched conditions: CIC-REARRANGED SARCOMA
Phase: PHASE2 • Sponsor: UNICANCER • Aim: Disease control
Last updated May 11, 2026 20:48 UTC
-
Hope for kids with advanced bone cancer: new combo trial launches
Disease control OngoingThis study tests whether adding three drugs (vincristine, irinotecan, and regorafenib) to standard chemotherapy helps people with metastatic Ewing sarcoma live longer without the cancer growing. About 437 participants aged 1 to 50 with newly diagnosed, spread cancer will be rando…
Matched conditions: CIC-REARRANGED SARCOMA
Phase: PHASE2, PHASE3 • Sponsor: Children's Oncology Group • Aim: Disease control
Last updated May 06, 2026 16:14 UTC